Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

The global atrial fibrillation treatment market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 13.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Atrial fibrillation (AFib) refers to a cardiac condition with irregular and rapid heart rate that increases the risks of stroke, heart failure and other heart-related complications. In this condition, the upper (atrial) chambers beat irregularly and out of coordination with the lower (ventricle) chambers of the heart, thereby causing heart palpitations, shortness of breath and fatigue. It can also lead to the development of blood clots that may disrupt the blood flow to other organs. The main types of AFib include paroxysmal, persistent, long-term persistent, and permanent AFib that can be treated with medications and other interventions to adjust the heart’s electrical impulses. 

The rising prevalence of cardiovascular diseases (CVDs) is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs). This, along with the steadily increasing geriatric population across the globe, is providing a boost to the market growth. Furthermore, the increasing preference for minimally invasive (MI) surgical procedures is also creating a positive impact on the demand for miniaturized surgical devices, implant surgeries and remote nursing. Additionally, various technological advancements, such as the development of catheter ablation devices to remove damaged heart tissues and innovative mapping and recording systems, is acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.

Breakup by Disorder Type:

  • Paroxysmal Atrial Fibrillation
  • Persistent Atrial Fibrillation
  • Permanent Atrial Fibrillation
  • Others
     

Breakup by Treatment Type:

  • Medical Procedures
    • Surgical Procedures
      • Maze Surgery
      • Catheter Ablation
    • Non-Surgical Procedures
      • Electric Cardioversion
      • Diagnostic Catheters 
      • Mapping and Recording Systems
      • Cardiac Monitors
      • Access Devices
      • Left Atrial Appendage and Closure Devices
      • Intracardiac Echocardiography (ICE) Systems
  • Medication
    • Anticoagulants
    • Anti-Arrhythmics
       

Breakup by End-User:

  • Hospitals
  • Cardiac Labs
  • Ambulatory Surgical Centers
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Abbott Laboratories, Atricure Inc., Biotronik, Boston Scientific Corporation, Cardiofocus Inc., Hansen Medical Inc. (Auris Health), Johnson & Johnson, Siemens Healthineers, Stereotaxis Inc., etc.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Disorder Type, Treatment Type, End-User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Abbott Laboratories, Atricure Inc., Biotronik, Boston Scientific Corporation, Cardiofocus Inc., Hansen Medical Inc. (Auris Health), Johnson & Johnson, Siemens Healthineers and Stereotaxis Inc
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global atrial fibrillation treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global atrial fibrillation treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the disorder type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global atrial fibrillation market treatment and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Atrial Fibrillation Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Disorder Type
    6.1    Paroxysmal Atrial Fibrillation
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Persistent Atrial Fibrillation
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Permanent Atrial Fibrillation
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Treatment Type
    7.1    Medical Procedures
        7.1.1 Market Trends
        7.1.2 Surgical Procedures
            7.1.2.1 Maze Surgery
            7.1.2.2 Catheter Ablation
        7.1.3 Non-Surgical Devices
            7.1.3.1 Electric Cardioversion
            7.1.3.2 Diagnostic Catheters 
            7.1.3.3 Mapping and Recording Systems
            7.1.3.4 Cardiac Monitors
            7.1.3.5 Access Devices
            7.1.3.6 Left Atrial Appendage and Closure Devices
            7.1.3.7 Intracardiac Echocardiography (ICE) Systems
        7.1.4 Market Forecast
    7.2    Medications
        7.2.1 Market Trends
        7.2.2 Drug Class
            7.2.2.1 Anticoagulants
            7.2.2.2 Anti-Arrhythmics    
        7.2.3 Market Forecast
8    Market Breakup by End-User
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Cardiac Labs
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Ambulatory Surgical Centers
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Competitive Landscape
    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Abbott Laboratories
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio 
           13.3.1.3 Financials 
           13.3.1.4 SWOT Analysis
        13.3.2    Atricure Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials 
           13.3.2.4 SWOT Analysis
        13.3.3    Biotronik
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio 
        13.3.4    Boston Scientific Corporation
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio 
           13.3.4.3 SWOT Analysis
        13.3.5    Cardiofocus Inc.
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
        13.3.6    Hansen Medical Inc. (Auris Health)
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio 
        13.3.7    Johnson & Johnson
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials 
           13.3.7.4 SWOT Analysis
        13.3.8    Siemens Healthineers
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio 
           13.3.8.3 Financials 
        13.3.9    Stereotaxis Inc.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio 
           13.3.9.3 Financials 
           13.3.9.4 SWOT Analysis

List of Figures

Figure 1: Global: Atrial Fibrillation Treatment Market: Major Drivers and Challenges
Figure 2: Global: Atrial Fibrillation Treatment Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Atrial Fibrillation Treatment Market: Breakup by Disorder Type (in %), 2020
Figure 4: Global: Atrial Fibrillation Treatment Market: Breakup by Treatment Type (in %), 2020
Figure 5: Global: Atrial Fibrillation Treatment Market: Breakup by End-User (in %), 2020
Figure 6: Global: Atrial Fibrillation Treatment Market: Breakup by Region (in %), 2020
Figure 7: Global: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 8: Global: Atrial Fibrillation Treatment (Paroxysmal Atrial Fibrillation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Atrial Fibrillation Treatment (Paroxysmal Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Atrial Fibrillation Treatment (Persistent Atrial Fibrillation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Atrial Fibrillation Treatment (Persistent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Atrial Fibrillation Treatment (Permanent Atrial Fibrillation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Atrial Fibrillation Treatment (Permanent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Atrial Fibrillation Treatment (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Atrial Fibrillation Treatment (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Atrial Fibrillation Treatment (Medical Procedures) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Atrial Fibrillation Treatment Market (Medical Procedures): Breakup by Type (in %), 2020
Figure 18: Global: Atrial Fibrillation Treatment Market (Surgical Procedures): Breakup by Type (in %), 2020
Figure 19: Global: Atrial Fibrillation Treatment (Medical Procedures) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Atrial Fibrillation Treatment (Medication) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Atrial Fibrillation Treatment Market (Medication): Breakup by Drug Classes (in %), 2020
Figure 22: Global: Atrial Fibrillation Treatment (Medication) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Atrial Fibrillation Treatment (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Atrial Fibrillation Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Atrial Fibrillation Treatment (Cardiac Labs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Atrial Fibrillation Treatment (Cardiac Labs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Atrial Fibrillation Treatment (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Atrial Fibrillation Treatment (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Atrial Fibrillation Treatment (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Atrial Fibrillation Treatment (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: North America: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: North America: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: United States: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: United States: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Canada: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Canada: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Asia Pacific: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Asia Pacific: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: China: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: China: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Japan: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Japan: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: India: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: India: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: South Korea: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: South Korea: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Australia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Australia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Indonesia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Indonesia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Europe: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Europe: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Germany: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Germany: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: France: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: France: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: United Kingdom: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: United Kingdom: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Italy: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Italy: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Spain: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Spain: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Russia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Russia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Latin America: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Latin America: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Brazil: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Brazil: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Mexico: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Mexico: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Middle East and Africa: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Middle East and Africa: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Global: Atrial Fibrillation Treatment Industry: SWOT Analysis
Figure 80: Global: Atrial Fibrillation Treatment Industry: Value Chain Analysis
Figure 81: Global: Atrial Fibrillation Treatment Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Atrial Fibrillation Treatment Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Disorder Type (in Million US$), 2021-2026
Table 3: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
Table 4: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by End-User (in Million US$), 2021-2026
Table 5: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Atrial Fibrillation Treatment Market Structure
Table 7: Global: Atrial Fibrillation Treatment Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links